Joseph M. Gibbons

Queen Mary University of London — United Kingdom

Medicine · Health Sciences

20h-index3.5kcitations51works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(31), COVID-19 Clinical Research Studies(30), Long-Term Effects of COVID-19(8), HIV Research and Treatment(7), COVID-19 epidemiological studies(7)

Publications49 total

Temporary 2-week suspension of methotrexate treatment to enhance COVID-19 vaccine response in people with immune-mediated inflammatory diseases: the VROOM RCT
Efficacy and Mechanism Evaluation·2025Open Access
HIV-1 Vpr alters cellular transcription by targeting the PAF1 complex
2025Open Access
Influence of individuals’ determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination
npj Vaccines·2024· 7 citedOpen Access
Preservation of memory B cell homeostasis in an individual producing broadly neutralising antibodies against HIV-1
2024Open Access
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial
The Lancet Rheumatology·2023· 19 citedOpen Access
Influence of age, sex, body habitus, vaccine type and anti-S serostatus on cellular and humoral responses to SARS-CoV-2 vaccination
2023Open Access
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
Nature Communications·2023· 32 citedOpen Access
Behçet's patients' response to COVID-19 vaccination
Clinical Immunology·2023· 1 cited
Curbside particulate matter and susceptibility to SARS–CoV-2 infection
Journal of Allergy and Clinical Immunology Global·2023· 7 citedOpen Access
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
iScience·2023· 15 citedOpen Access
Large Clones of Pre-Existing T Cells Drive Early Immunity Against SARS-COV-2 and LCMV Infection
SSRN Electronic Journal·2023Open Access
COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
Leukemia·2022Open Access
Persistent symptoms after COVID-19 during the first wave are not associated with differential immunity to SARS-CoV-2
2022Open Access
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
2022· 3 citedOpen Access
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
EBioMedicine·2022· 68 citedOpen Access
Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial
Nutrients·2022· 37 citedOpen Access
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
Cell Reports Methods·2022· 10 citedOpen Access
Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study
The Journal of Infectious Diseases·2022· 19 citedOpen Access
Influence of vitamin D supplementation on SARS-CoV-2 vaccine efficacy and immunogenicity
2022· 1 citedOpen Access
Immune boosting by B.1.1.529 <b>(</b> Omicron) depends on previous SARS-CoV-2 exposure
Science·2022· 350 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Áine McKnight(43), Corinna Pade(38), Daniel M. Altmann(25), Rosemary J. Boyton(25), Charlotte Manisty(24), James Moon(24), Tim Brooks(24), Mahdad Noursadeghi(23), Thomas A. Treibel(21), Amanda Semper(21), George Joy(19), Mala K. Maini(19), Ashley Otter(18), Marianna Fontana(14), Benny Chain(13), Teresa Cutiño‐Moguel(13), Aneesh Chandran(12), Jessica Jones(12), Meleri Jones(12), Wing-Yiu Jason Lee(11)